Brenda Schmidt, MS, MBS, moderates a discussion on the diabetes online community and the opportunity for social media in type 1 and type 2 diabetes care. She is joined by panelists Hope Warshaw, MMSc, RD, CDE, BC-ADM; Thomas C. Hawkins, MD, MS; Amy Tenderich, MA, and Kerri Sparling.
%jwplayer%
Brenda Schmidt, MS, MBS, moderates a discussion on the diabetes online community and the opportunity for social media in type 1 and type 2 diabetes care. She is joined by panelists Hope Warshaw, MMSc, RD, CDE, BC-ADM; Thomas C. Hawkins, MD, MS; Amy Tenderich, MA, and Kerri Sparling.
Amy Tenderich views social media as both a place for open communication as well as advocacy that allows the patient community to unite under a collective voice. She explains that online forums have become a critical method for patients to learn and better understand the disease from peers who share similar experiences.
Not only do these forums open communication lines from 1 patient to another, but it also provides a platform for patients to voice their opinions and thoughts to the pharmaceutical companies that develop the medications and devices for the patients, as well as to the FDA, payers, and various other stakeholders in order to better understand what it is that real patients want and need.
“People wanted to share their experiences in the real world, they wanted to ask each other questions about how they were titrating, dosing and about whatever effects they were experiencing, so there’s a great opportunity on the therapy side for people to learn from each other,” Tenderich said.
However, Warshaw believes that amongst the large patient population that exists in the Diabetes Care community, the engagement with these online forums is minimal. Sparling believes that the minimal representation of individuals diagnosed with type 2 diabetes mellitus may be due to the social stigma attached to the disease. The panelists discuss how patients can become more engaged with the diabetes care community, both online and in the real world.
Intensive Blood Pressure Regimen Lowers CVD Risk for People With Diabetes
November 19th 2024Reducing systolic blood pressure to less than 120 mmHg lowered the risk of major cardiovascular events for most people with type 2 diabetes in the Blood Pressure Control Target in Diabetes trial.
Read More
Exploring Pharmaceutical Innovations, Trust, and Access With CVS Health's CMO
July 11th 2024On this episode of Managed Care Cast, we're talking with the chief medical officer of CVS Health about recent pharmaceutical innovations, patient-provider relationships, and strategies to reduce drug costs.
Listen
Contributor: The Diabetes Vendor Resource Guide—A Useful Directory for Employers
November 13th 2024Employees living with diabetes often face unique challenges, such as managing blood sugar levels, balancing medication, and preventing complications, all while maintaining their professional responsibilities. This condition can lead to increased absenteeism, reduced productivity, and rising health care costs.
Read More
How Can Employers Leverage the DPP to Improve Diabetes Rates?
February 15th 2022On this episode of Managed Care Cast, Jill Hutt, vice president of member services at the Greater Philadelphia Business Coalition on Health, explains the Coalition’s efforts to reduce diabetes rates through the Diabetes Prevention Program (DPP).
Listen
Intensive Blood Pressure Regimen Lowers CVD Risk for People With Diabetes
November 19th 2024Reducing systolic blood pressure to less than 120 mmHg lowered the risk of major cardiovascular events for most people with type 2 diabetes in the Blood Pressure Control Target in Diabetes trial.
Read More
Exploring Pharmaceutical Innovations, Trust, and Access With CVS Health's CMO
July 11th 2024On this episode of Managed Care Cast, we're talking with the chief medical officer of CVS Health about recent pharmaceutical innovations, patient-provider relationships, and strategies to reduce drug costs.
Listen
Contributor: The Diabetes Vendor Resource Guide—A Useful Directory for Employers
November 13th 2024Employees living with diabetes often face unique challenges, such as managing blood sugar levels, balancing medication, and preventing complications, all while maintaining their professional responsibilities. This condition can lead to increased absenteeism, reduced productivity, and rising health care costs.
Read More
How Can Employers Leverage the DPP to Improve Diabetes Rates?
February 15th 2022On this episode of Managed Care Cast, Jill Hutt, vice president of member services at the Greater Philadelphia Business Coalition on Health, explains the Coalition’s efforts to reduce diabetes rates through the Diabetes Prevention Program (DPP).
Listen
2 Commerce Drive
Cranbury, NJ 08512